Drawing for A2 BIOTHERAPEUTICS

USPTO serial 88564436

A2 BIOTHERAPEUTICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RHIM, ANDREW
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with A2 BIOTHERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joi A. White

Joi A. White Carr & Ferrell LLP120 Constitution DriveMenlo Park, CA 94025UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005T-cell pharmaceutical products for the treatment of cancer; therapeutic targets, namely, proteins or protein complexes, for the treatment and prevention of cancer; therapeutic cells, for medical use, for the treatment and prevention of cancer; therapeutic proteins and therapeutic antibodies, for medical use, for the treatment and prevention of cancer in humans; therapeutics and cellular therapies in the nature of proteins and protein complexes for the treatment of cancer; biologics, namely, proteins and protein complexes, for in-vitro diagnostic use for the treatment of cancerACTIVE—
042Provision of, and identification and development of, therapeutic targets, namely, proteins and protein complexes, for others for the treatment and prevention of cancer; development of therapeutics and cellular therapies, namely, pharmaceutical, biological and medical therapies for the treatment of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; scientific research and development services; providing scientific information in the fields of treatment and prevention of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 20, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 20, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 4, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 2, 2021EX1GSOU EXTENSION 1 GRANTED—
Feb 2, 2021EXT1SOU EXTENSION 1 FILED—
Feb 2, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 18, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 23, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 23, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 14, 2020ALIEASSIGNED TO LIE—
May 11, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 6, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 5, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 5, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 31, 2019DOCKASSIGNED TO EXAMINER—
Aug 22, 2019MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 21, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 6, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance